Bionomics Ltd. (OTC: BNOEF) is a fully integrated, international drug discovery and development company creating new therapies that serve large unmet needs in cancer and central nervous system disorders such as depression, anxiety and Alzheimer’s. Bionomics has created proprietary technology platforms for each step in the drug discovery and development process. One of the most notable platforms is Multicore, which involves a suite of integrated synthetic methods that gives access to complex drug-like molecules. For more information, visit the company’s website at www.bionomics.com.au